{"entity":{"id":"nct07664150","kind":"trial","name":"CW-301 FIH Study of CAN016","aka":[],"tldr":"A phase 1/2 trial of CAN016 in advanced solid tumours, run by Canwell Biotech Limited, now recruiting.","summary":"CW-301 FIH Study of CAN016 is a phase 1/2 interventional study registered as NCT07664150 by Canwell Biotech Limited, with 90 participants planned, started 2026-06-18 and due to reach its primary completion in 2028-12-30. Interventions recorded: CAN016.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT07664150","url":"https://clinicaltrials.gov/study/NCT07664150"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT07664150","phase":"1/2","setting":"A Phase I/II, Open-Label, Non-Randomized, Multi-Centre First-in-Human Study of CAN016 in Patients With Advanced Solid Tumors","sponsor":"Canwell Biotech Limited","enrolled":90,"outcomes":[]},"route":"/trials/nct07664150/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}]}}